Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 3/20 | 0.48 |
| ▸ | KDM2A | Q9Y2K7 | 3/20 | 0.48 |
| ▸ | KDM4A | O75164 | 2/20 | 0.48 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.48 |
| ▸ | TET3 | O43151 | 1/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 8/20 | 0.41 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.41 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | GABRP | O00591 | 2/20 | 0.41 |
| ▸ | GABRD | O14764 | 2/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28235276 | 0.87 | FFAR4 (0.46) | TET2KDM2AKDM4AKDM4CTET3 | |
| SCHEMBL14300790 | 0.83 | GABRP (0.46) | TET2KDM2AKDM4AKDM4CTET3 | |
| SCHEMBL141783 | 0.73 | FOLH1 (0.61) | TET2KDM2AKDM4AKDM4CTET3 | |
| SCHEMBL8768068 | 0.73 | FOLH1 (0.61) | TET2KDM2AKDM4AKDM4CTET3 | |
| SCHEMBL8769194 | 0.73 | FOLH1 (0.61) | TET2KDM2AKDM4AKDM4CTET3 | |
| SCHEMBL29356795 | 0.73 | FOLH1 (0.61) | TET2KDM2AKDM4AKDM4CTET3 | |
| SCHEMBL21999079 | 0.72 | FOLH1 (0.38) | TET2KDM2AKDM4AKDM4CTET3 | |
| SCHEMBL27546130 | 0.71 | TET2 (0.44) | TET2KDM2AKDM4AKDM4CTET3 | |
| SCHEMBL28185763 | 0.71 | AKR1B1 (0.41) | — | |
| SCHEMBL10614825 | 0.69 | TET2 (0.60) | TET2KDM2AKDM4AKDM4CTET3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170101351-A1 | CHELATED COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | SCOTT G. WILLIAMS, LLC | 2017-04-13 | — | — | US | disclosed |
| US-9540289-B2 | Chelated compositions and methods of making and using the same | SCOTT G. WILLIAMS, LLC (US) | 2017-01-10 | — | — | US | disclosed |
| US-20150299059-A1 | CHELATED COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | SCOTT G. WILLIAMS, LLC | 2015-10-22 | — | — | US | disclosed |
| US-9034071-B2 | Chelated compositions and methods of making and using the same | SCOTT G. WILLIAMS, LLC (GE) | 2015-05-19 | — | — | US | disclosed |
| US-20140179945-A1 | CHELATED COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | SCOTT G. WILLIAMS, LLC (US) | 2014-06-26 | — | — | US | disclosed |
| US-20120160001-A1 | CHELATED COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | SCOTT G. WILLIAMS, LLC (US) | 2012-06-28 | — | — | US | disclosed |
| WO-2012088138-A1 | CHELATED COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | SCOTT G. WILLIAMS, LLC (US) | 2012-06-28 | — | — | WO | disclosed |
| US-20100291017-A1 | Hair Treatment Compositions | CONOPCO, INC. D/B/A UNILEVER | 2010-11-18 | — | — | US | disclosed |
| EP-1959917-A1 | HAIR TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2008-08-27 | — | — | EP | disclosed |
| WO-2007068399-A1 | HAIR TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2007-06-21 | — | — | WO | disclosed |
| US-4215000-A | CROWN ETHER COMPLEXES; RAPID REACTION | SHELL DEVELOPMENT COMPANY (US) | 1980-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100291017-A1 | Hair Treatment Compositions | OAT, NACA, BCAT2 | TET2 209/4885KDM2A 1683/4885KDM4A 1936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.